General manager and Research director

Dr. Ming-Chung Kan

 

Education

Ph.D: University of Massachusetts Medical School program of biomedical Science. 2008

 

Career

Postdoctoral Fellow at University of Massachusetts Medical School. (2008-2010)

Founder of Vaxsia Biomedical Inc. (2010-now)

 

Achievements

Establish a drug screening platform for identification of ESCRT-II complex modulator.

Inventor of VADEX.

 

Publication

Kan, M.C., Oruganty-Das, A., Cooper-Morgan, A., Jin, G., Swanger, S.A., Bassell, G.J., Florman, H., van Leyen, K., and Richter, J.D. (2010) CPEB4 is a cell survival protein retained in the nucleus upon ischemia or endoplasmic reticulum calcium depletion. Mol Cell Biol 30, 5658-5671.

Huang, Y.S.*, Kan, M.C.*, Lin, C.L., and Richter, J.D. (2006) CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA. EMBO J. 25, 4865-4876. * Equal Contribution.

Cao, Q., Huang, Y.S., Kan, M.C., and Richter, J.D. (2005) Amyloid precursor proteins anchor CPEB to membranes and promote polyadenylation-induced translation. Mol. Cell. Biol. 25, 10930-10939.

Chao, M.Y., Kan, M.C., and Lin-Chao, S. (1995) RNAII transcribed by IPTG-induced T7 RNA polymerase is non-functional as a replication primer for ColE1-type plasmids in Escherichia coli. Nucleic Acids Res. 23, 1691-1695.

 

Scientific Consultants

Dr. Gan-Guang Liou

Asistant Researcher, Institute of Molecular and Genomic Medicine, National Health Research Institutes